Literature DB >> 17999164

A biodegradable pH-sensitive micelle system for targeting acidic solid tumors.

Vijay A Sethuraman1, Myung Cheon Lee, You Han Bae.   

Abstract

A new pH-sensitive micelle delivery system based on TAT cell penetrating peptide and biodegradable sulfonamide grafted disulfide polymer is presented. The system consists of two components: (1) A polymeric micelle made of Poly(L-lactic acid)-b-poly(ethylene glycol) (PLLA-b-PEG) conjugated to TAT (TAT-micelle), (2) A pH-sensitive diblock copolymer (poly(L-cystine bisamide-g-sulfadiazine))-b-PEG (PCBS-b-PEG). The anionic PCBS complexed with cationic TAT of TAT-micelles forms the final carrier. PCBS showed rapid degradation in the presence of cysteine. The TAT-micelles showed increase in particle size between pH 8.0 and 7.0 upon mixing with PCBS-b-PEG indicating complexation. As the pH was further decreased (pH 6.8 to 6.0) two populations were observed, one of normal TAT-micelles and the other of aggregated PCBS-b-PEG. Flow cytometry showed significantly higher uptake of TAT-micelles at pH 6.6 indicating deshielding compared to pH 7.4. The anticancer drug doxorubicin (DOX) was encapsulated into the TAT-micelles, and the in vitro cytotoxicity at different pHs was evaluated. The system was able to distinguish pHs 7.2 and 7.0 in terms of cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999164     DOI: 10.1007/s11095-007-9480-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  35 in total

Review 1.  Causes and consequences of tumour acidity and implications for treatment.

Authors:  M Stubbs; P M McSheehy; J R Griffiths; C L Bashford
Journal:  Mol Med Today       Date:  2000-01

2.  Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.

Authors:  Todd L Kaneshiro; Tianyi Ke; Eun-Kee Jeong; Dennis L Parker; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2006-06-01       Impact factor: 4.200

3.  Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice.

Authors:  Yuda Zong; Xinghe Wang; K Craig Goodrich; Aaron M Mohs; Dennis L Parker; Zheng-Rong Lu
Journal:  Magn Reson Med       Date:  2005-04       Impact factor: 4.668

Review 4.  Receptor-targeted cancer therapy.

Authors:  Mark Richter; Hongtao Zhang
Journal:  DNA Cell Biol       Date:  2005-05       Impact factor: 3.311

5.  pH-induced micelle formation of poly(histidine-co-phenylalanine)-block-poly(ethylene glycol) in aqueous media.

Authors:  Goo Myun Kim; You Han Bae; Won Ho Jo
Journal:  Macromol Biosci       Date:  2005-11-04       Impact factor: 4.979

6.  pH-induced solubility transition of sulfonamide-based polymers.

Authors:  Seong Il Kang; You Han Bae
Journal:  J Control Release       Date:  2002-04-23       Impact factor: 9.776

Review 7.  Polymeric micelles for drug delivery.

Authors:  S R Croy; G S Kwon
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

8.  Subcellular trafficking of HPMA copolymer-Tat conjugates in human ovarian carcinoma cells.

Authors:  Aparna Nori; Keith D Jensen; Monica Tijerina; Pavla Kopecková; Jindrich Kopecek
Journal:  J Control Release       Date:  2003-08-28       Impact factor: 9.776

Review 9.  Microenvironmental and cellular consequences of altered blood flow in tumours.

Authors:  N Raghunand; R A Gatenby; R J Gillies
Journal:  Br J Radiol       Date:  2003       Impact factor: 3.039

10.  Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles.

Authors:  Fariyal Ahmed; Dennis E Discher
Journal:  J Control Release       Date:  2004-04-16       Impact factor: 9.776

View more
  26 in total

Review 1.  Cancer nanomedicines targeting tumor extracellular pH.

Authors:  Li Tian; You Han Bae
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-25       Impact factor: 5.268

2.  Lysosomal delivery of a lipophilic gemcitabine prodrug using novel acid-sensitive micelles improved its antitumor activity.

Authors:  Saijie Zhu; Dharmika S P Lansakara-P; Xinran Li; Zhengrong Cui
Journal:  Bioconjug Chem       Date:  2012-04-18       Impact factor: 4.774

3.  Digital switching of local arginine density in a genetically encoded self-assembled polypeptide nanoparticle controls cellular uptake.

Authors:  Sarah R Macewan; Ashutosh Chilkoti
Journal:  Nano Lett       Date:  2012-05-31       Impact factor: 11.189

4.  Acid-Sensitive Magnetic Nanoparticles as Potential Drug Depots.

Authors:  Shy Chyi Wuang; Koon Gee Neoh; En-Tang Kang; Deborah E Leckband; Daniel W Pack
Journal:  AIChE J       Date:  2011-06       Impact factor: 3.993

5.  Micelle Mixtures for Coadministration of Gemcitabine and GDC-0449 To Treat Pancreatic Cancer.

Authors:  Melek Karaca; Rinku Dutta; Yildiz Ozsoy; Ram I Mahato
Journal:  Mol Pharm       Date:  2016-04-27       Impact factor: 4.939

Review 6.  Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents.

Authors:  Sarah R MacEwan; Ashutosh Chilkoti
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-09-13

Review 7.  Cell-penetrating peptides: achievements and challenges in application for cancer treatment.

Authors:  Meong Cheol Shin; Jian Zhang; Kyoung Ah Min; Kyuri Lee; Youngro Byun; Allan E David; Huining He; Victor C Yang
Journal:  J Biomed Mater Res A       Date:  2013-07-30       Impact factor: 4.396

8.  Micellar carrier based on methoxy poly(ethylene glycol)-block-poly(epsilon-caprolactone) block copolymers bearing ketone groups on the polyester block for doxorubicin delivery.

Authors:  He Yueying; Zhang Yan; Gu Chunhua; Dai Weifeng; Lang Meidong
Journal:  J Mater Sci Mater Med       Date:  2009-10-15       Impact factor: 3.896

9.  The architecture of ligand attachment to nanocarriers controls their specific interaction with target cells.

Authors:  Rupa R Sawant; Rishikesh M Sawant; Amit A Kale; Vladimir P Torchilin
Journal:  J Drug Target       Date:  2008-08       Impact factor: 5.121

10.  Targeting ion transport in cancer.

Authors:  E Oosterwijk; R J Gillies
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.